Immediate Impact

50 standout
Sub-graph 1 of 25

Citing Papers

The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
2024 Standout
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities
2024 Standout
2 intermediate papers

Works of Yulan Ye being referenced

CircRNA_103765 acts as a proinflammatory factor via sponging miR-30 family in Crohn’s disease
2021
The epidemiology and risk factors of inflammatory bowel disease.
2015

Author Peers

Author Last Decade Papers Cites
Yulan Ye 63 74 126 105 88 13 304
Kim Olievier 84 77 114 53 129 10 349
Timothy S. Sadiq 47 63 96 131 61 19 315
Sean Flynn 44 26 117 128 94 14 346
Wan Feng 29 42 168 105 78 15 335
Glenn Oliveira 23 36 129 116 46 13 324
Sylvie Sordello 44 51 168 47 29 13 365
Sean Mateer 111 38 152 56 42 9 354
A. Venturi 25 52 133 56 62 21 353
Kangchen Chen 18 79 140 68 70 13 311
Francesca Invernizzi 27 48 118 81 69 12 368

All Works

Loading papers...

Rankless by CCL
2026